Article Details

Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance 'Gene Writing' – A ...

Retrieved on: 2021-01-12 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance 'Gene Writing' – A .... View article details on hiswai:

Excerpt

iAs of the date of this press release, SoftBank Group Corp. has made capital contributions to allow investments by SoftBank Vision Fund 2 (“SVF 2”) in ...

Article found on: www.cadillacnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo